1. Pérez-García, Jésica, Martel-Martel, Abel, García-Vallés, Paula, Perea, José, González-Sarmiento, Rogelio. 2022. Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration. In Cancers, 14, . doi:10.3390/cancers14164029. https://pubmed.ncbi.nlm.nih.gov/36011023/
2. Zhang, Qi, Li, Fei, Li, Tingting, Wang, Xu, Li, Qiang. 2024. Nomo1 deficiency causes autism-like behavior in zebrafish. In EMBO reports, 25, 570-592. doi:10.1038/s44319-023-00036-y. https://pubmed.ncbi.nlm.nih.gov/38253686/
3. Perea, José, García, Juan Luis, Pérez, Jessica, Urioste, Miguel, González-Sarmiento, Rogelio. . NOMO-1 gene is deleted in early-onset colorectal cancer. In Oncotarget, 8, 24429-24436. doi:10.18632/oncotarget.15478. https://pubmed.ncbi.nlm.nih.gov/28416736/
4. Marian, Teresa A, Wei, Zhubo. 2020. Reply to Zhao et al.: NOMO1 is a potential target gene of MRTFB. In Proceedings of the National Academy of Sciences of the United States of America, 117, 7570-7571. doi:10.1073/pnas.2000772117. https://pubmed.ncbi.nlm.nih.gov/32184332/
5. Huang, Yen-Tsung, Zhang, Yi, Wu, Zhijin, Michaud, Dominique S. . Genotype-based gene signature of glioma risk. In Neuro-oncology, 19, 940-950. doi:10.1093/neuonc/now288. https://pubmed.ncbi.nlm.nih.gov/28339748/